We are international
Donate
TEXT SIZE   


International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Mellqvist - Improved progression free survival with bortezomib consolidation after high dose melphalan; results of a randomized phase III trial
Ulf-Henrik Mellqvist, MD
Sahlgrenska University Hospital
Gothenburg, Sweden
May 3-6, 2011
Paris, France
05.06.11
 related articles